What is the approximate price of pomalidomide produced in India and is it cheap?
Pomalidomide (Pomalidomide) is an important targeted immunomodulatory drug for the treatment of multiple myeloma and has been widely recognized around the world. The original drug was developed by the American company Celgene under the trade name Pomalyst. It has been used for the long-term treatment of relapsed or refractory multiple myeloma in European and American markets. Due to the high price of original drugs, especially in countries and regions not yet covered by medical insurance, the burden is heavy for ordinary patients. Therefore, many patients are looking towards generic drugs in the Indian market.

As a major global producer of generic drugs, India’s pharmaceutical industry is known for its high cost performance, and pomalidomide is no exception. At present, well-known Indian pharmaceutical companies such as NATCO and Hetero have launched legal and compliant generic versions of pomalidomide. The drug ingredients are basically the same as the original drug, and have the same active ingredients, dosage specifications and administration methods. Common specifications include 2 mg 21 tablets and 4 mg 21 tablets, which can meet the treatment needs of patients at different stages. According to unofficial channel data, the price of a box of 2mg or 4mg is approximately RMB 1,000 to RMB 2,000. The specific price may fluctuate due to exchange rate fluctuations, supply channels, and regional differences.
Compared with the price of original drugs, which can easily reach tens of thousands of yuan per box, Indian generic drugs are indeed much cheaper, and the cost-effectiveness advantage is very obvious. Especially for myeloma patients who need long-term medication, choosing a more affordable generic version can significantly reduce financial pressure. In addition, these generic drugs have passed the approval of the drug regulatory agency in India and have also passed the verification of clinical use in many countries, indicating that they have certain guarantees in terms of efficacy and safety.
However, it needs to be reminded that although Indian generic drugs have price advantages, one must be extremely careful in choosing purchase channels. It is recommended that patients obtain it through formal medical institutions or qualified cross-border drug platforms, and avoid purchasing through unknown purchasing channels to prevent buying fake or inferior drugs. At the same time, medication should be used in a standardized manner under the guidance of a doctor to avoid changing or adjusting the treatment plan on your own.
Reference materials:https://en.wikipedia.org/wiki/Pomalidomide
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)